MNOV - MEDICINOVA INC
1.36
0.060 4.412%
Share volume: 40,162
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$1.30
0.06
0.05%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-09-2024 | 08-08-2024 | 11-13-2024 | 02-19-2025 | 05-13-2025 | 08-14-2025 | 11-12-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 134.599 K | 123.319 K | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 134.599 K | 123.319 K | |
| nan% | nan% | nan% | inf% | -8.38% | ||||
| Operating expenses | 3.136 M | 3.046 M | 3.309 M | 3.184 M | 3.203 M | 3.742 M | 3.504 M | |
| Selling general and admin | 1.354 M | 1.400 M | 1.450 M | 1.276 M | 1.363 M | 1.553 M | 1.921 M | |
| Research and development | 1.782 M | 1.646 M | 1.859 M | 1.907 M | 1.840 M | 2.189 M | 1.583 M | |
| Total expenses | 3.136 M | 3.046 M | 3.309 M | 3.184 M | 3.203 M | 3.742 M | 3.504 M | |
| -2.85% | 8.62% | -3.79% | 0.59% | 16.84% | -6.34% | |||
| Operating income | -3.136 M | -3.046 M | -3.309 M | -3.184 M | -3.203 M | -3.607 M | -3.381 M | |
| Ebit | -3.152 M | -3.064 M | -3.300 M | -3.199 M | -3.200 M | -3.606 M | -3.391 M | |
| Pretax income | -2.755 M | -2.628 M | -2.852 M | -2.809 M | -2.864 M | -3.281 M | -3.050 M | |
| -4.59% | 8.52% | -1.51% | 1.96% | 14.56% | -7.03% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -2.755 M | -2.628 M | -2.852 M | -2.815 M | -2.864 M | -3.281 M | -3.050 M | |
| 4.59% | -8.52% | 1.32% | -1.76% | -14.56% | 7.03% |